|
Apr. 9, 2007 --Nanogen, Inc., developer of advanced diagnostic products, has obtained a United States Government Service Administration (GSA) Schedule contract for its NanoChip 400 microarray instrument and reagents.
The contract enables Nanogen to be listed on an approved GSA Schedule and sell its NanoChip products directly to government agencies such as the National Institutes of Health (NIH), military hospitals, and Veteran's Administration (VA) hospitals. Nanogen's inclusion as a GSA Schedule Vendor allows government customers to obtain approved pricing and license terms from a pre-qualified vendor. Government agencies typically have separate GSA and non-GSA budgets, and therefore inclusion as a GSA vendor allows Nanogen broader access to government customers' budgets.
The contract means that both current and new customers will be able to expedite future purchases through the GSA ordering process.
The NanoChip 400 instrument is an automated multiplexing platform that laboratories use to detect genetic sequences. Tests can be performed using reagents supplied by Nanogen, or laboratories can develop their own assays. The NanoChip instrument employs Nanogen's core microarray technology, which utilizes patented microfluidics and electronic technology to automate sample handling and detection of results.
| 
News & Features 
Add RSS Feed
